The current stock price of TRNS is 58.2 USD. In the past month the price increased by 6.4%. In the past year, price decreased by -45.1%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| URI | UNITED RENTALS INC | 19.35 | 53.07B | ||
| GWW | WW GRAINGER INC | 25.93 | 49.01B | ||
| FAST | FASTENAL CO | 39.09 | 48.02B | ||
| FERG | FERGUSON ENTERPRISES INC | 22.1 | 44.79B | ||
| FTAI | FTAI AVIATION LTD | 39.56 | 17.77B | ||
| QXO | QXO INC | 86.2 | 14.53B | ||
| WSO.B | WATSCO INC -CL B | 27.52 | 14.29B | ||
| WSO | WATSCO INC | 27.17 | 14.11B | ||
| WCC | WESCO INTERNATIONAL INC | 20.09 | 12.39B | ||
| CNM | CORE & MAIN INC-CLASS A | 20.14 | 10.70B | ||
| AIT | APPLIED INDUSTRIAL TECH INC | 25.44 | 9.97B | ||
| AL | AIR LEASE CORP | 10.06 | 7.18B |
Transcat, Inc. engages in the provision of calibration and laboratory instrument services. The company is headquartered in Rochester, New York and currently employs 1,245 full-time employees. The company is focused on providing services and products to highly regulated industries, particularly the life science industry, which includes pharmaceuticals, biotechnology, medical devices, as well as aerospace and defense, and energy and utilities. The company provides periodic on-site services, mobile calibration services, pickup and delivery, and in-house services at Calibration Service Centers strategically located across the United States, Puerto Rico, Canada, and Ireland. Its segments include Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualifications, preventative maintenance, consulting and other related services. The Distribution segment sells and rents national and proprietary branded instruments to customers globally.
TRANSCAT INC
35 Vantage Point Dr
Rochester NEW YORK 14624 US
CEO: Lee D. Rudow
Employees: 1104
Phone: 15853527777
Transcat, Inc. engages in the provision of calibration and laboratory instrument services. The company is headquartered in Rochester, New York and currently employs 1,245 full-time employees. The company is focused on providing services and products to highly regulated industries, particularly the life science industry, which includes pharmaceuticals, biotechnology, medical devices, as well as aerospace and defense, and energy and utilities. The company provides periodic on-site services, mobile calibration services, pickup and delivery, and in-house services at Calibration Service Centers strategically located across the United States, Puerto Rico, Canada, and Ireland. Its segments include Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualifications, preventative maintenance, consulting and other related services. The Distribution segment sells and rents national and proprietary branded instruments to customers globally.
The current stock price of TRNS is 58.2 USD. The price increased by 0.61% in the last trading session.
TRNS does not pay a dividend.
TRNS has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
TRNS stock is listed on the Nasdaq exchange.
10 analysts have analysed TRNS and the average price target is 105.74 USD. This implies a price increase of 81.68% is expected in the next year compared to the current price of 58.2.
The PE ratio for TRANSCAT INC (TRNS) is 34.85. This is based on the reported non-GAAP earnings per share of 1.67 and the current share price of 58.2 USD.
ChartMill assigns a technical rating of 1 / 10 to TRNS. When comparing the yearly performance of all stocks, TRNS is a bad performer in the overall market: 90.22% of all stocks are doing better.
ChartMill assigns a fundamental rating of 5 / 10 to TRNS. TRNS has an average financial health and profitability rating.
Over the last trailing twelve months TRNS reported a non-GAAP Earnings per Share(EPS) of 1.67. The EPS decreased by -15.66% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 3.75% | ||
| ROA | 2.34% | ||
| ROE | 3.84% | ||
| Debt/Equity | 0.38 |
10 analysts have analysed TRNS and the average price target is 105.74 USD. This implies a price increase of 81.68% is expected in the next year compared to the current price of 58.2.
For the next year, analysts expect an EPS growth of 47.1% and a revenue growth 18.13% for TRNS